What are lymphoid aggregates in the ileum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lymphoid Aggregates in the Ileum

Lymphoid aggregates in the ileum are collections of lymphoid tissue (primarily lymphocytes) that can be either normal gut-associated lymphoid tissue (GALT) or pathological transmural lymphoid hyperplasia, with the latter being a highly specific diagnostic feature of Crohn's disease when found away from areas of ulceration.

Normal vs. Pathological Lymphoid Aggregates

Normal Gut-Associated Lymphoid Tissue (GALT)

  • The ileum naturally contains organized lymphoid structures including Peyer's patches (multi-follicular aggregates) and isolated lymphoid follicles (ILF) distributed along the intestinal wall 1

  • These normal structures are located primarily on the antimesenteric border of the ileum, with greatest density in the most distal segments 2

  • Normal lymphoid follicles in the ileum serve as key antigen sampling and adaptive immune inductive sites within the intestinal wall 1

Pathological Transmural Lymphoid Aggregates

In resection specimens, transmural lymphoid aggregates (transmural lymphoid hyperplasia), particularly when located away from areas of ulceration, represent one of the two most specific microscopic indicators for Crohn's disease (CD), along with non-crypt-related granulomas 3

Clinical Significance and Diagnostic Value

Crohn's Disease

  • Transmural lymphoid aggregates are typical discriminating features for CD versus ulcerative colitis (UC) in surgical specimens 3

  • In studies of colectomy specimens from fulminant colitis, granulomas and lymphoid aggregates proved to be the two most specific indicators for CD diagnosis 3

  • The earliest visible mucosal lesions of CD are small aphthous ulcers that typically develop over lymphoid follicles 3

  • Unique T-lymphocyte aggregates (TLAs) localized in ileal villi have been identified in 66% of CD patients, composed mainly of CD4+ CD45RO+ T cells with CD68+ macrophages 4

  • These TLAs were detected even in CD patients without granulomas on histopathology and in patients whose disease was limited to the colon, making them diagnostically valuable 4

Other Conditions

  • Transmural lymphoid aggregates can also occur in segmental colitis associated with diverticulosis (SCAD), though this primarily affects the sigmoid colon rather than ileum 3

  • Nodular lymphoid hyperplasia (NLH) presents as multiple 2-5mm nodules in the terminal ileum, consisting of mass lymphoid follicles with germinal centers containing predominantly CD20+ B cells 5

  • NLH patients typically present with diarrhea (70.8%), abdominal pain (60%), hematochezia (46.2%), anemia (40%), and hypoproteinemia (21.5%) 5

Key Diagnostic Pitfalls

  • Location matters: Transmural lymphoid aggregates are only diagnostically significant for CD when found away from areas of ulceration 3

  • Normal Peyer's patches and isolated lymphoid follicles should not be confused with pathological transmural lymphoid hyperplasia—the key distinction is the transmural distribution and association with chronic inflammation in CD 3

  • Histological examination is necessary to exclude malignancy and differentiate between normal GALT, benign NLH, and pathological CD-associated aggregates 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.